How to Successfully Complete a Narcotic Tapering with Functional Restoration



Similar documents
Judith Martin, MD Medical Director, Substance Abuse Services, San Francisco DPH

Opioid Treatment Agreement

Opioid Agreement for Center for Pain Management S.C.

CONTROLLED SUBSTANCE CONTRACT

The Challenges of Narcotic Tapering in Chronic Pain Treatment

Opioid Contracts: A Tool for Providing Relief and Preventing Abuse?

Policy on Opioid Drugs for Non-Cancer Pain and Patient Medication Agreement

03/20/12. Recognize the right of patients to appropriate assessment and management of pain

Treating Addiction in Chronic Pain Patients A Clinical Journey. Brad Anderson, MD Chief, Department of Addiction Medicine Kaiser Permanente Northwest

Guidelines for Cancer Pain Management in Substance Misusers Dr Jane Neerkin, Dr Chi-Chi Cheung and Dr Caroline Stirling

Like cocaine, heroin is a drug that is illegal in some areas of the world. Heroin is highly addictive.

OPIOID PAIN MEDICATION Agreement and Informed Consent

Prescription Drug Abuse

CNCP and Addiction. Disclosures 17/02/2015. CPSNS CPSNL Atlantic Mentorship Network P&A. John Fraser February 18, 2015

Pain, Addiction & Methadone

Appendix to Tennessee Department of Health: Tennessee Clinical Practice Guidelines for Outpatient Management of Chronic Non- Malignant Pain

What you should know about treating your pain with opioids. Important information on the safe use of opioid pain medicine.

What you need for Your to know Safety about longterm. opioid pain care. What you need to know about long-term opioid

Addiction Medicine for FP / GP. Dr. Francisco Ward, DABPMR/PM SetonPainRehab.com setonpr@gmail.com

Neurobiology and Treatment of Opioid Dependence. Nebraska MAT Training September 29, 2011

William J. Lorman, PhD, MSN, PMHNP-NP, CARN-AP Vice President & Chief Clinical Officer, Livengrin Foundation, Inc. Clinical Asst. Professor, Graduate

Share the important information in this Medication Guide with members of your household.

Opiate Abuse and Mental Illness

PRESCRIPTION DRUG ABUSE prevention

Hulpverleningsmodellen bij opiaatverslaving. Frieda Matthys 6 juni 2013

*** Please present this form and all insurance ID cards to the receptionist at this time. ***

Protecting your employees, physicians and you.

Methamphetamine. Like heroin, meth is a drug that is illegal in some areas of the world. Meth is a highly addictive drug.

Treatment of opioid use disorders

Benzodiazepine Detoxification and Reduction of Long term Use

MEDICALLY SUPERVISED OPIATE WITHDRAWAL FOR THE DEPENDENT PATIENT. An Outpatient Model

New York State Office of Alcoholism & Substance Abuse Services Addiction Services for Prevention, Treatment, Recovery

The Chemical Coper Steven D. Passik, PhD

02 DEPARTMENT OF PROFESSIONAL AND FINANCIAL REGULATION

Treatments for drug misuse

TENNESSEE BOARD OF MEDICAL EXAMINERS POLICY STATEMENT OFFICE-BASED TREATMENT OF OPIOID ADDICTION

Patients are still addicted Buprenorphine is simply a substitute for heroin or

UNM Pain Center: Addressing New Mexico s Public Health Crises of Pain, Addiction, and Unintentional Opioid Overdose Deaths

Fact Sheet. Queensland Spinal Cord Injuries Service. Pain Management Following Spinal Cord Injury for Health Professionals

PRIMARY CARE PHYSICIAN: REFERRED TO: LAST NAME: FIRST NAME: SS# DOB: SEX: MARITAL STATUS: HOME PHONE: CELL: ADDRESS:

THE COMMONWEALTH OF MASSACHUSETTS Department of Industrial Accidents

MAT Counselor Education Course Exam Questions Packet Part 1

The Federation of State Medical Boards 2013 Model Guidelines for Opioid Addiction Treatment in the Medical Office

How To Know If You Should Be Treated

OVERVIEW WHAT IS POLyDRUG USE? Different examples of polydrug use

ALCOHOLISM, ALCOHOL DEPENDENCE AND THE EFFECTS ON YOUR HEALTH.

Transitioning a Pain Program Away From Chronic Opioid Prescribing

Substance Abuse Issues in Pain Management

Prescription Medication Abuse: Skills for Prevention and Intervention

Treatment and Interventions for Opioid Addictions: Challenges From the Medical Director s Perspective

Background & Significance

It is important that you tell your family and the people closest to you of this increased sensitivity to opioids and the risk of overdose.

Michigan Guidelines for the Use of Controlled Substances for the Treatment of Pain

Alcohol Addiction. Introduction. Overview and Facts. Symptoms

ADVANCED BEHAVIORAL HEALTH, INC. Clinical Level of Care Guidelines

Opioid Analgesic Medication Information

Assessment and Management of Opioid, Benzodiazepine, and Sedative-Hypnotic Withdrawal

How To Treat A Drug Addiction

Drug overdose death rates by state per 100,000 people (2008) SOURCE: National Vital Statistics System, 2008

Disclosure. C.R. Sullivan, MD 1. Carl R. Sullivan, M.D. Professor and Director Addictions Program The West Virginia Model

Guidelines for the Prescribing, Supply and Administration of Methadone and Buprenorphine on Transfer of Care

Medical Malpractice Treatment Alprazolam benzodiazepine - A Case Study

Teen Misuse and Abuse of Alcohol and Prescription Drugs. Information for Parents

EPIDEMIC 4.6 % OF INDIVIDUALS USED PAIN RELIEVERS FOR NON-MEDICAL REASONS. 1.5 MILLION YOUNG ADULTS USED PAIN RELIEVERS IN THE PAST MONTH.

TREATMENT MODALITIES. May, 2013

Naltrexone Shared Care Guideline for the treatment of alcohol dependence and opioid dependance

Information for Pharmacists

Treatment of Opioid Dependence: A Randomized Controlled Trial. Karen L. Sees, DO, Kevin L. Delucchi, PhD, Carmen Masson, PhD, Amy

Interventional Spine Care New Patient History and Intake Form

Care Management Council submission date: August Contact Information

Update and Review of Medication Assisted Treatments

BUPRENORPHINE. the facts about. for Treatment of Opioid Addiction

Produced and Published by The Cabin Chiang Mai, Alcohol and Drug Rehab Centre. Copyright and How is it Treated?

OPIOIDS. Petros Levounis, MD, MA Chair Department of Psychiatry Rutgers New Jersey Medical School

New Patient Evaluation

MEDICATION GUIDE SUBOXONE (Sub-OX-own) (buprenorphine and naloxone) Sublingual Film for sublingual or buccal administration (CIII)

These changes are prominent in individuals with severe disorders, but also occur at the mild or moderate level.

the facts about NALTREXONE

HAWAII BOARD OF MEDICAL EXAMINERS PAIN MANAGEMENT GUIDELINES

KENTUCKY ADMINISTRATIVE REGULATIONS TITLE 201. GENERAL GOVERNMENT CABINET CHAPTER 9. BOARD OF MEDICAL LICENSURE

How To Prevent Alcohol And Drug Abuse At Stanford

How To Know If You Can Get Help For An Addiction

Experiences of Assessing Misuse, Abuse and Opioid Use Disorders in Patients with Pain on Opioid Therapy

CONTROLLED SUBSTANCE (NARCOTIC) AGREEMENT

If the only tool you have is a hammer, you tend to see every problem as a nail.

ST. CLAIR COUNTY COMMUNITY MENTAL HEALTH Date Issued: 07/09 Date Revised: 09/11;03/13;06/14;07/15

Opioids and the Injured Worker Tools for Successful Outcomes

This module reviews the following: Opioid addiction and the brain Descriptions and definitions of opioid agonists,

Acute Pain Management in the Opioid Dependent Patient. Maripat Welz-Bosna MSN, CRNP-BC

EPIDEMIOLOGY OF OPIATE USE

Update on Buprenorphine: Induction and Ongoing Care

OTC Abuse. Dr. Eman Said Abd-Elkhalek Lecturer of Pharmacology & Toxicology Faculty of Pharmacy Mansoura University

Reintegration. Recovery. Medication-Assisted Treatment for Alcohol Dependence. Reintegration. Resilience

methadonefact.qxd 8/11/01 2:05 PM Page 1 INFORMATION Advantages of methadone treatment DEPRESSANT Methadone maintenance Pregnancy METHADONE

Painkiller addiction and pseudoaddiction in SCD (presentation 2 in a series of 3)

Medication treatments for opioid use disorders

Science and Treatment Prescription Drug Addiction Treatment. Karen Miotto, M.D. David Geffen School of Medicine

MANAGEMENT OF CHRONIC NON MALIGNANT PAIN

Naltrexone and Alcoholism Treatment Test

Integrating Medication- Assisted Treatment (MAT) for Opioid Use Disorders into Behavioral and Physical Healthcare Settings

Transcription:

How to Successfully Complete a Narcotic Tapering with Functional Restoration Fernando Branco M.D. F.A.A.P.M.R. Medical Director Rosomoff Comprehensive Rehabilitation Center and Brucker Biofeedback Center Miami Jewish Health Systems Disclaimer: I have no financial relationship in regard to the content of this presentation

Disclaimer I am the Medical Director of the Rosomoff Comprehensive Rehabilitation Center at MJHS This Presentations does not contain off-label and/or investigational use of drugs or products

Conundrums of Chronic Pain Care: Avoid Overuse of Narcotics Functional Restoration Return to Work Treat Psychological and Physical Problems Avoid Overuse of Interventional Treatments More Deaths from prescription drugs than illicit drugs, Fort Lauderdale had more Pain Clinics than McDonald s

P A I N Can t see it Can t measure it Can t diagnose it on x-ray or MRI 75% of general population will have abnormal MRIs bulging or herniated discs or narrowing..and NO PAIN.

Pain Cycles

Drug Addict? Drug Abuse? Excessive use of a drug for purposes for which it is not medically intended.

The Risk of Addiction Published rates of abuse and/or addiction in chronic pain populations are 3-19% Known risk factors for addiction to any substance are good predictors for opioid abuse 1. Past cocaine use, h/o of alcohol or cannabis use 2. Lifetime history of substance use disorder 3. Family history of substance abuse, history of legal problems and drug and alcohol abuse 4. Tobacco dependence 5. History of severe depression and anxiety Ives et al 2006 Reid et al 2002 Michna et al 2004 Akbik et al 2006

Addiction is A primary, chronic, neurobiological disease with genetic, psychosocial and environmental factors influencing its development and manifestations A clinical syndrome: Loss of control Compulsive use Continued use despite harm Craving Savage SR et al JPain Symptom Manage 2003

Pseudoaddiction Opiophobia Overestimate potency and duration of action Fear of being scammed Fear of addiction potential Morgan J 1985 Smith 1989

Yellow Flags Complaints of more medications needed Drug hoarding Requesting specific pain medications Openly acquiring similar medications from other providers Occasional unsanctioned dose escalation Nonadherence to other recommendations for pain therapy Passik SD Mayo Clinic Proc 2009

Red Flags Deterioration in functioning at work and socially Illegal activities selling, forging, buying from nonmedical sources Injecting and snorting medication Multiple episodes of lost or stolen scripts Resistance to change therapy despite adverse effects Refusal to comply with random drug screens Concurrent abuse of alcohol or illicit drugs Use of multiple physicians and pharmacies Passik SD Mayo Clinic Proc 2009

Narcotic Cycle Patients need higher doses to achieve results = TOLERANCE Eventually lack of pain relief may lead to steady increases in amount and types of pain medication Long term use of narcotics leads to OPIOD INDUCED ABNORMAL PAIN SENSITIVITY

Narcotics Eliminate production of your own body s ENDORPHINS Shut the endorphin system down Lead to HYPERalgesia and HYPERsensitivity to pain

Journal of Opioid Management Significant pain reduction in chronic pain patients after detoxification from high-dose opioids Sept/Oct 2006 21 of the 23 patients showed marked decrease in pain following tapering from narcotics!!

Publications Opioid-induced hyperalgesia: pathophysiology & clinical implications: Journal of Opioid Management 2008 Opioid induced abnormal pain sensitivity Current Pain Headache Report 2006 Adverse effects of chronic opioid therapy for chronic musculoskeletal pain National Rev of Rheumatology 2010 Hyperalgesia in opioid-managed chronic pain and opioid-dependent patients Journal of Pain 2009

SERIOUS SIDE EFFECTS Narcotics slow down the action of the bowel / intestines resulting in severe constipation almost always requiring another medication to help relieve this symptom Urinary retention inability to empty bladder most often in males Hypogonadism decreased sex drive, erectile dysfunction often requires need for additional meds Testosterone therapy

What is the Solution?

MYOFASCIAL SYNDROME Sciatica Neuropathy Sinus problems / dental pain Carpal Tunnel Migraine Leads to misdiagnosis & incorrect tx J. Travell, 1976

Goals of Treatment Improve quality of life Restore optimum levels of function Reduce or eliminate pain Reduce or eliminate addictive pain medications Enable become independent of the healthcare system (related to pain)

EFFECTIVE TREATMENT Return to the basics: Physical and Psychological Rehabilitation Physical Medicine True Multidisciplinary Approach What is the definition of insanity? "The definition of insanity is doing the same thing over and over and expecting a different result. Benjamin Franklin, Albert Einstein, Chinese Anonymous

Outpatient Weaning Setting s Office Outpatient drug detox program Outpatient Comprehensive Pain Management Program (community weaning) Patient Characteristics On lower opioid dose, simpler medication plan (1-2 meds), more gradual wean Motivated Low to medium psychosocial issues Community social support for plan Weaning Process Speed of weaning: dose decrease by 20-25% every 10-14 days Monitoring: Urinary drug screen, pain behaviors, drug use and seeking, functional status Support: Meds for withdrawal (temporary), physical rehabilitation (functional approach), follow-up every 1-2 weeks, but available by phone daily, proactive check-in; cognitive behavioral approach Case Management Red flags: Increased pain complaints: Can t bear it, Carrier did not approve X, Equipment did not arrive, pharmacy issues, worrisome symptoms. Actions: contact injured worker in person if possible, review treatment recommendations and symptoms management, contact treating team, return to provider if not able to assure compliance, do not approve increase in meds or new diagnostic evaluations or treatment changes unless recommended by current treatment team; disallow return to prior prescribers.

Inpatient Weaning Setting s Residential drug detox program Weaning as part of Comprehensive Pain Management Program* Rapid detox (addressed later) Patient Characteristics On high doses of opioids and/or complex drug regimens or needs more rapid detox Not motivated or resistant to weaning Medium to high psychosocial issues; history of psychiatric diagnosis, prior failed detox Poor community social support for plan Weaning Process Speed of weaning: dose decrease by 20-25% every 3 days Monitoring: Urinary drug screen, pain behaviors, drug use and seeking, functional status Support: Meds for withdrawal (temporary), physical rehabilitation (functional approach), follow-up every day, available by phone daily, proactive check-in, onsite problem resolution; aggressive physical rehabilitation to separate physical from drug issues; multiple modalities to treat withdrawal Case Management Red flags: Increased pain complaints, limited participation, desire to quit program, family support not adequate or detrimental, core beliefs unchanged, anger at carrier, multiple addiction issues. Post-discharge issues. Actions: Family engagement, clear-cut discharge pre-planning regarding pharmacy limitation, approved physicians, day-to-day problem resolution using providers from pain program. Urine drug screens. Onsite psychological support, cognitive behavioral approach.

Replacement Therapies Setting s Outpatient: bridge to detoxification Methadone, Buprenorphine products Patient Characteristics On high doses of opioids predominantly Indicated for addiction; very limited as a pain solution Motivated wean off current meds, agrees to terms of process or case who will not wean, out of control Low to medium psychosocial issues Good community social support for plan Weaning Process Speed of weaning: induction requires care, but is relatively quick; subsequent taper is slow Monitoring: Urinary drug screen, pain behaviors, drug use and seeking, functional status Support: Functional restoration, cognitive behavioral therapies, support groups (AA, NA) Case Management Red flags: Lower risk of abuse if no other meds prescribed; pain complaints likely to continue. Patient may advocate to go back on pain medications. Control. Actions: Consider inpatient or outpatient detoxification.

Rapid Detoxification Not proven safe or effective Indications: Few, if any. Low doses of narcotics. Claims: Painless, cheaper, safe. Realities: Very risky (high death rate) from coma detoxification, does not treat root of the problem, severe withdrawals and craving on discharge without any support. Risks: Death, suicide due to severe withdrawals, pain not addressed, immediately resuming use of narcotics. Ideal candidate: Maybe patient with no addiction history who medically needs to be off meds ASAP. The data supporting the safety and effectiveness of opioid antagonist agent detoxification under sedation or general anesthesia is limited, and adequate safety has not been established. Given that the adverse events are potentially life threatening, the value of antagonist-induced withdrawal under heavy sedation or anesthesia is not supported.

Possible Symptoms of Withdrawal Flu-like aches and pains Sweating, tearing, runny nose Chills, flushing Goose bumps Ants crawling on your skin Loss of appetite Headache Anxiety Restlessness / Restless legs Severe insomnia Nausea, vomiting, diarrhea, abdominal pain

PHYSICAL THERAPY

S T R E ACTIVE T C H I N PASSIVE G

ICE HEAT

NEUROMUSCULAR MASSAGE

PAIN RELIEF AIDS SELF CARE

P R E V E N T I N J U R Y OCCUPATIONAL THERAPY

OCCUPATIONAL THERAPY POSTURE BALANCE

ERGONOMICS Human Performance Testing Workplace Design / Analysis Job Simulation

WORKPLACE ANALYSIS AND DESIGN

BIOFEEDBACK THERAPY Relaxation Re-education Body Mechanics Posture

MOTOR DYSFUNCTION EVALUATION ABNORMAL

PSYCHOLOGY SERVICES Evaluation Manage behavioral crises. Support during Tx Individual, group, family Self Hypnosis Training Relaxation & Stress Management

QUESTIONS??